$0.72+0.06 (+8.80%)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
Definitive Healthcare Corp. in the Healthcare sector is trading at $0.72 with a market capitalization of $93M. Wall Street consensus targets $2.20 (6 analysts), implying a +206.4% move over the next 12 months. The stock is currently near its 52-week low of $0.62, remaining 63.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $55.93Mβ | $61.53Mβ | $60.05Mβ | $60.75Mβ | $59.19M |
| Gross Profit | $41.65Mβ | $46.91Mβ | $45.99Mβ | $46.61Mβ | $43.76M |
| Operating Income | -$4.84Mβ | -$6.71Mβ | -$3.38Mβ | -$3.50Mβ | -$6.99M |
| Net Income | -$138.62Mβ | -$9.31Mβ | -$14.84Mβ | -$7.55Mβ | -$107.23M |
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers an...
The United States market has shown positive momentum recently, climbing 1.6% over the past week and 28% over the last year, with expectations of continued earnings growth. While the term "penny stock" may evoke images of speculative trading from a bygone era, these stocks can still present valuable opportunities when backed by strong financials and potential for growth. This article explores several penny stocks that stand out for their financial resilience and potential to offer investors...
We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Definitive Healthcare Corp. (NASDAQ:DH) is among the best penny stocks on this list. TheFly reported on May 8 that Baird reduced its price target on DH to $1.10 from $1.30 in a revised outlook, while a Neutral rating was maintained. [β¦]
Definitive Healthcare Corp. ( NASDAQ:DH ) shareholders are probably feeling a little disappointed, since its shares...
Definitive Healthcare (NASDAQ:DH) reported first-quarter fiscal 2026 results that management said came in βat or above the high endβ of guidance on both revenue and profitability, while reiterating that the company remains in a transition period as it works to return to consistent top-line growth.
Moby summary of Definitive Healthcare Corp.'s Q1 2026 earnings call